A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
NCT07173244 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-09-15
Summary
This prospective, multicenter, non-interventional, observational, real-world study was designed to evaluate the safety and efficacy of an adebrelimab-based regimen in patients with advanced solid tumors.
Conditions
Interventions
- DRUG
-
Adebrelimab
adebrelimab-based regimen
Sponsors & Collaborators
-
Tianjin First Central Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-15
- Primary Completion
- 2027-09-30
- Completion
- 2029-09-30
More Related Trials
-
Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen
NCT07137039 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
NCT06236997 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer
NCT06784206 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
NCT06512051 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients
NCT06335355 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
NCT07035392 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT07170995 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC
NCT06424899 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors
NCT06537505 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma
NCT07238569 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
NCT06764368 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
NCT07198217 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor
NCT07327294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
NCT07073534 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.
NCT06173219 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors
NCT05134948 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
NCT06768307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer
NCT06009848 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
NCT07042100 ·Status: RECRUITING ·Phase: PHASE1
-
Adebrelimab and Chemoradiotherapy in High-risk LANPC
NCT06349889 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC)
NCT01745445 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
NCT03792750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors
NCT05122572 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer
NCT05416775 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
NCT05235542 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2